JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 1 78-84
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montravers, F.
Right arrow Articles by Talbot, J.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montravers, F.
Right arrow Articles by Talbot, J.-N.

Evaluation of FDG Uptake by Renal Malignancies (Primary Tumor or Metastases) Using a Coincidence Detection {gamma} Camera

Françoise Montravers, Dany Grahek, Khaldoun Kerrou, Nassima Younsi, Jean-Dominique Doublet, Bernard Gattegno, Jérôme Rossert, Maris-Alyette Costa de Beauregard, Philippe Thibault and Jean-Noël Talbot

Services de Médecine Nucléaire, d'Urologie, et de Néphrologie A et B, Hôpital Tenon, Paris, France

Correspondence: For correspondence or reprints contact: Françoise Montravers, MD, Service de Médecine Nucléaire, Hôpital Tenon, 4 rue de la Chine, F-75020 Paris, France.

ABSTRACT

The aim of this study was to evaluate the usefulness of FDG scanning using an ordinary {gamma} camera equipped with coincidence detection (CDET) for 2 renal cancer indications: characterization and staging of renal masses before nephrectomy and search for recurrence after nephrectomy. Methods: Between September 1997 and June 1998, a whole-body scan and at least 1 tomoscintigram were obtained on 23 occasions in 22 patients (fasting for at least 6 h) using a Prism XP 2000 CDET {gamma} camera; scanning was begun 45 min after intravenous injection of 150–250 MBq FDG. Results: Postoperative histologic evidence was obtained from 13 of 16 patients who underwent FDG using a CDET {gamma} camera before renal surgery; 4 renal masses did not accumulate FDG (3 true-negatives, 1 false-negative), whereas 9 renal tumors accumulated FDG (8 true-positives, 1 false-positive). In the other 3 patients, only 1 extrarenal site of FDG uptake was checked and confirmed on histologic examination: a bone metastasis from renal cell carcinoma in 2 cases and lymph node metastasis from a squamous cell carcinoma (3 true-positives). The primary local and regional staging of the malignant renal tumors was accurate in the 9 patients who underwent nephrectomy (8 true-negatives, 1 true-positive). The primary distant staging was positive in 1 case (focus in the chest corresponding to a probable true-positive on follow-up). In the 7 examinations performed because of suspected recurrence of renal cell carcinoma several months after nephrectomy, metastases were visualized by FDG in 4 patients, confirmed by biopsy in 2 patients, and confirmed by conventional imaging or follow-up (or both) in 2 patients. The other 3 patients had negative FDG scans, corresponding to probable true-negative results on follow-up. Conclusion: FDG using a CDET {gamma} camera can be used effectively for the staging and restaging of renal tumors and might be useful for characterization of the primary renal tumor in doubtful cases.

Key Words: renal cancer • FDG • coincidence detection • {gamma} camera




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
C. S. Ng, C. G. Wood, P. M. Silverman, N. M. Tannir, P. Tamboli, and C. M. Sandler
Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance
Am. J. Roentgenol., October 1, 2008; 191(4): 1220 - 1232.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Even-Sapir, H. Lerman, A. Figer, M. Rabau, G. Livshitz, M. Inbar, and M. Gutman
Role of 18F-FDG Dual-Head Gamma-Camera Coincidence Imaging in Recurrent or Metastatic Colorectal Carcinoma
J. Nucl. Med., May 1, 2002; 43(5): 603 - 609.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K.-J. Langen, A. R. Börner, V. Müller-Mattheis, K. Hamacher, H. Herzog, R. Ackermann, and H. H. Coenen
Uptake of Cis-4-[18F]Fluoro-L-Proline in Urologic Tumors
J. Nucl. Med., May 1, 2001; 42(5): 752 - 754.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.